Back to Main

Novo Nordisk Enters Oversold Territory - Tale of the Tape

Posted: 6/25/2013 5:30:00 AM
Referenced Stocks: NVO

Novo Nordisk 's ( NVO ) share price has entered into oversold territory with an RSI value of 23.85. The Zacks Consensus Estimate on Novo Nordisk's earnings for the full year period have moved higher by 16 cents over the past two months to $8.27 per share. Currently, Novo Nordisk is a Zacks #2 Rank ("Buy"), suggesting that now might be a good time to get in on ( NVO ) after its recent drop.

NOVO-NORDISK AS (NVO): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research